extellia THERAPEUTICS Logo (WIPO, 06/29/2016)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark extellia THERAPEUTICS was filed as Figurative mark on 06/29/2016 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Circles #Letters presenting a special form of writing #Several circles, juxtaposed, tangential or intersecting #Letters in light-coloured characters on a dark background
| Trademark form | Figurative mark |
| File reference | 1313291 |
| Countries | 
|
| Base trademark |
No. 86864974,
January 4, 2016
|
| Application date | June 29, 2016 |
| Expiration date | August 26, 2019 |
Trademark owner
Suite 303,
25 First Street
US
25 First Street
US
Trademark representatives
254 Commercial Street
Portland ME 04101
US
goods and services
05
Pharmaceutical and biological preparations to be delivered
or applied ex vivo to human cells based on gene, genome and
cellular editing, modulation, modification, engineering,
regulation, and repair therapy for use in human
therapeutics; diagnostic preparations for medical purposes
based on gene, genome and cellular editing, modulation,
modification, engineering, regulation, repair and therapy
42
Scientific and medical research in the fields of gene,
genome and cellular editing, modulation, modification,
engineering, regulation, repair and therapy to develop human
pharmaceutical and biological preparations to be delivered
or applied ex vivo to human cells for use in human
therapeutics and diagnostic products and services;
scientific study and research in the fields of gene, genome
and cellular editing, modulation, modification, engineering,
regulation, repair and therapy to develop human
pharmaceutical and biological preparations to be delivered
or applied ex vivo to human cells for use in human
therapeutics and diagnostic products and services; design of
bioinformatic algorithms and models for use in scientific
and medical research in the fields of gene, genome and
cellular editing, modulation, modification, engineering,
regulation, repair and therapy to develop human
pharmaceutical and biological preparations to be delivered
or applied ex vivo to human cells for use in human
therapeutics and diagnostic products and services
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| March 11, 2020 | 2020/15 Gaz | US | RAW: Total Ceasing Effect |
| November 1, 2018 | 2018/45 Gaz | TR | Rejection |
| March 15, 2018 | 2018/11 Gaz | CN | Rejection |
| October 12, 2017 | 2017/41 Gaz | MX | Rejection |
| October 3, 2017 | 2017/41 Gaz | IN | Rejection |
| June 29, 2017 | 2017/28 Gaz | RU | Rejection |
| March 15, 2017 | 2017/11 Gaz | EM | Rejection |
| January 12, 2017 | 2017/3 Gaz | JP | Rejection |
| January 11, 2017 | 2017/2 Gaz | AU | Rejection |
| June 29, 2016 | 2016/40 Gaz | US | Registration |
ID: 141313291